[HTML][HTML] Advancements in PSMA ligand radiolabeling for diagnosis and treatment of prostate cancer: a systematic review
Y Yan, H Zhuo, T Li, J Zhang, M Tan, Y Chen - Frontiers in Oncology, 2024 - frontiersin.org
Prostate cancer (PCa), a leading global health concern, profoundly impacts millions of men
worldwide. Progressing through two stages, it initially develops within the prostate and …
worldwide. Progressing through two stages, it initially develops within the prostate and …
A Comparison of 68Ga-PSMA PET/CT-Based Split Renal Function with 99mTc-MAG3 Renography in Patients with Metastatic Castration-Resistant Prostate Carcinoma Treated …
L Gabela, T Mkhize, B Hadebe, L Harry, T Nxasana… - Diagnostics, 2024 - mdpi.com
Background: Physiological PSMA expression in the cells of the proximal renal tubules and
consecutive radiopharmaceutical binding and retention could potentially lead to radioligand …
consecutive radiopharmaceutical binding and retention could potentially lead to radioligand …
Dependence of Renal Uptake on Kidney Function in [68Ga]Ga-PSMA-11 PET/CT Imaging
F Gühne, T Schilder, P Seifert, C Kühnel… - Diagnostics, 2024 - mdpi.com
(1) Background: PSMA ligand PET/CT is increasingly important for diagnostics of prostate
cancer and other tumor diseases. In particular, the radiopharmaceutical [68Ga] Ga-PSMA-11 …
cancer and other tumor diseases. In particular, the radiopharmaceutical [68Ga] Ga-PSMA-11 …
[HTML][HTML] Early treatment response assessment with [177Lu] PSMA whole-body-scintigraphy compared to interim PSMA-PET
D Ventura, P Rassek, P Schindler… - Cancer …, 2024 - cancerimagingjournal.biomedcentral …
Prostate-specific membrane antigen positron emission tomography (PSMA-PET) is an
essential tool for patient selection before radioligand therapy (RLT). Interim-staging with …
essential tool for patient selection before radioligand therapy (RLT). Interim-staging with …
Determination of the optimal imaging protocol for [18F] PSMA-PET-CT for the detection of bone metastases in prostate cancer patients
L Bredensteiner, D Ventura, P Rassek… - Nuklearmedizin …, 2024 - thieme-connect.com
Aim Prostate-specific membrane antigen-positron emission tomography (PSMA-PET) is a
widely used diagnostic tool in patients with prostate cancer (PC). However, due to the limited …
widely used diagnostic tool in patients with prostate cancer (PC). However, due to the limited …
ПЭТ/КТ с 18 F-PSMA-1007 в диагностике первичного очага и местного рецидива светлоклеточного почечно-клеточного рака в сравнении с 18 F-ФДГ …
ВС Ильяков, АИ Пронин, АВ Парнас… - Онкологический …, 2024 - oncoradjournal.ru
Аннотация Введение: Предпринимались попытки использовать различные ПЭТ-
трейсеры, помимо 18 F-ФДГ, в диагностике почечно-клеточного рака (ПКР) …
трейсеры, помимо 18 F-ФДГ, в диагностике почечно-клеточного рака (ПКР) …